CenExel Clinical Research
Private Company
Total funding raised: $150M
Overview
CenExel Clinical Research, founded in 2017, is a private clinical research services company operating a network of dedicated research sites. It functions as a site-level partner for sponsors and CROs, offering patient recruitment, trial execution, and data collection services. The company emphasizes operational excellence, significant collective investigator experience, and large, well-equipped facilities to accelerate clinical development for its clients. Its business model is purely service-based, generating revenue from contracted research services.
Technology Platform
Operational platform consisting of a network of dedicated clinical research sites ('Centers of Excellence') with standardized procedures, large-scale facilities (inpatient beds, on-site labs), and integrated patient recruitment and trial management systems.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
CenExel competes in the fragmented clinical research site sector against academic medical centers, hospital-based research institutes, and other private site networks (e.g., ICON plc's site network, Parexel's affiliated sites, and regional players). Its key differentiators are its large, sponsor-dedicated facilities and emphasis on high-volume, professionally-managed trial execution, as opposed to smaller, physician-investigator practices.